| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | signaling adaptor activity | 3.70e-05 | 129 | 193 | 8 | GO:0035591 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 1.72e-04 | 54 | 193 | 5 | GO:0030159 | |
| Pubmed | TPP2 ZNF318 ARMCX4 BCL9 TMEM132B DDX3X EFTUD2 MAGI2 TAX1BP1 SVIL PEX5 WNK2 SORBS2 DLGAP4 TRIOBP EFHD2 SORBS1 SHANK3 SNW1 CELSR2 CCAR1 SCRIB CABIN1 PCDH8 UNC13A | 2.49e-10 | 963 | 196 | 25 | 28671696 | |
| Pubmed | RRP1B DDX3X EFTUD2 SVIL EMG1 DSC2 DSC3 ZNF629 LARP1 RBM6 CCAR1 SCRIB | 5.92e-08 | 274 | 196 | 12 | 34244482 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 CARD10 BCL9 ZNF236 PRAG1 ITGB5 AHDC1 GGA3 ZGPAT SLC38A10 TNRC18 MAP3K11 PLK3 WNK2 FBRSL1 FAM83H HIVEP3 SLC2A4RG CELSR2 KANK3 CTDP1 NINL CABIN1 | 8.08e-08 | 1105 | 196 | 23 | 35748872 |
| Pubmed | A genome-wide association study (GWAS) for bronchopulmonary dysplasia. | 1.32e-06 | 34 | 196 | 5 | 23897914 | |
| Pubmed | TPP2 BCORL1 ZNF318 BCL9 AHDC1 DDX3X STAU1 TNRC18 EMG1 CZIB PNP UBQLN1 EIF4H RBM33 DOCK8 ZNF629 LARP1 SNW1 CCZ1 CCAR1 | 4.83e-06 | 1103 | 196 | 20 | 34189442 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | RABL3 STT3A STAU1 ZGPAT SLC38A10 PTPN14 MAVS MAP3K11 CA8 CAVIN3 RAB34 MICAL2 BSCL2 | 5.82e-06 | 499 | 196 | 13 | 22810586 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | RRP1B PPP1R12B ZNF318 PRAG1 EFTUD2 SVIL SORBS2 TRIOBP LARP1 SNW1 SCRIB | 7.24e-06 | 361 | 196 | 11 | 30344098 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PDE9A ZNF236 ITGB5 AHDC1 STT3A TNRC18 IGSF9 BOD1L1 WNK2 CACNB3 FRMPD2 FBRSL1 TRIOBP LARP1 HIVEP3 MICAL2 KNDC1 RBM6 CCAR1 CDK5RAP1 BSCL2 SPIDR SLC4A5 | 1.25e-05 | 1489 | 196 | 23 | 28611215 |
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 1.78e-05 | 57 | 196 | 5 | 23080069 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STAU1 EFTUD2 ZGPAT PTPN14 RECQL5 RECQL4 ALOX12B PNP USP36 DSC3 EIF4H FAM83H SMTN RIN1 SNW1 RAB34 MICAL2 MDC1 CCAR1 SCRIB PALLD | 2.86e-05 | 1353 | 196 | 21 | 29467282 |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 24220340 | ||
| Pubmed | Phloridzin improves lipoprotein lipase activity in stress-loaded mice via AMPK phosphorylation. | 3.16e-05 | 2 | 196 | 2 | 24932810 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 19246456 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 22773878 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 18622425 | ||
| Pubmed | Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells. | 3.16e-05 | 2 | 196 | 2 | 29605720 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 21398697 | ||
| Pubmed | Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue. | 3.16e-05 | 2 | 196 | 2 | 29555209 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 22820186 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 9878247 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 32034094 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 25597500 | ||
| Pubmed | Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes. | 3.16e-05 | 2 | 196 | 2 | 27034464 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 32460791 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 17088546 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 33003532 | ||
| Pubmed | RRP1B BRAF MAVS MAP3K11 LARP1 EFHD2 TACC2 RIN1 CTDP1 RBM6 SCRIB PALLD | 3.17e-05 | 503 | 196 | 12 | 16964243 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PRAG1 DDX3X PTPN14 BRAF SVIL BOD1L1 SORBS2 DSC2 NTRK3 ZNF629 LARP1 SORBS1 AKT1S1 FAM83H SCRIB PALLD | 3.34e-05 | 861 | 196 | 16 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZNF318 BCL9 EFTUD2 BRAF SVIL SORBS2 LARP1 AKT1S1 SMTN PRICKLE3 MDC1 CTDP1 RBM6 CCAR1 SCRIB | 3.69e-05 | 774 | 196 | 15 | 15302935 |
| Pubmed | Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications. | 4.53e-05 | 69 | 196 | 5 | 34941261 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ZNF318 AHDC1 DDX3X STAU1 MAVS LARP1 TACC2 SMTN SNW1 CCZ1 PALLD | 4.85e-05 | 444 | 196 | 11 | 34795231 |
| Pubmed | RRP1B GINS1 GGA3 IGSF9 WNK2 USP36 RELCH FBRSL1 TRIOBP LARP1 MDC1 NINL | 5.15e-05 | 529 | 196 | 12 | 14621295 | |
| Pubmed | 6.13e-05 | 14 | 196 | 3 | 15836771 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | BCORL1 TMEM132B QRICH2 SLC38A10 RECQL4 PKHD1 KCNS2 BOD1L1 VWC2 HSPBAP1 LARP1 ARHGAP9 DARS2 SCRIB | 8.19e-05 | 736 | 196 | 14 | 29676528 |
| Pubmed | RRP1B PPP1R12B AHDC1 DDX3X STAU1 EFTUD2 TNRC18 PTPN14 BRAF TAX1BP1 SVIL CNOT2 PTBP3 UBQLN1 EIF4H LARP1 FAM83H SNW1 MICAL2 | 8.90e-05 | 1247 | 196 | 19 | 27684187 | |
| Pubmed | PCSK5 DDX3X RECQL4 EMG1 ZNF629 FBRSL1 LARP1 AP5B1 LPL CCAR1 CDK5RAP1 SCRIB PALLD | 8.98e-05 | 650 | 196 | 13 | 38777146 | |
| Pubmed | 9.26e-05 | 42 | 196 | 4 | 18985028 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 32160108 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 19028676 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 22078753 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 12510380 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 27929370 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 21385318 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 30905785 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 16125169 | ||
| Pubmed | Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration. | 9.44e-05 | 3 | 196 | 2 | 20952587 | |
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 23975055 | ||
| Pubmed | Compositionally different desmosomes in the various compartments of the human hair follicle. | 9.44e-05 | 3 | 196 | 2 | 9810708 | |
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 21397862 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 27736772 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 35488290 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 9389456 | ||
| Pubmed | Assignment of the human genes for desmocollin 3 (DSC3) and desmocollin 4 (DSC4) to chromosome 18q12. | 9.44e-05 | 3 | 196 | 2 | 7774948 | |
| Pubmed | Inhibition of SNW1 association with spliceosomal proteins promotes apoptosis in breast cancer cells. | 9.44e-05 | 3 | 196 | 2 | 25450007 | |
| Pubmed | MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression. | 9.44e-05 | 3 | 196 | 2 | 32132651 | |
| Pubmed | SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. | 9.44e-05 | 3 | 196 | 2 | 29059173 | |
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 22566688 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 37583001 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 7929347 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 20581395 | ||
| Pubmed | KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas. | 9.44e-05 | 3 | 196 | 2 | 33046021 | |
| Pubmed | Human X chromosome exome sequencing identifies BCORL1 as contributor to spermatogenesis. | 9.44e-05 | 3 | 196 | 2 | 32376790 | |
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 21170385 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 33239171 | ||
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 23176178 | ||
| Pubmed | Structure and function of desmosomal proteins and their role in development and disease. | 9.44e-05 | 3 | 196 | 2 | 14523549 | |
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 17088906 | ||
| Pubmed | A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase. | 9.44e-05 | 3 | 196 | 2 | 29899144 | |
| Pubmed | FAM83H and SCRIB stabilize β-catenin and stimulate progression of gastric carcinoma. | 9.44e-05 | 3 | 196 | 2 | 32564009 | |
| Pubmed | Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities. | 9.44e-05 | 3 | 196 | 2 | 33482195 | |
| Pubmed | The gene encoding tripeptidyl peptidase II maps to chromosome 1 in the mouse. | 9.44e-05 | 3 | 196 | 2 | 8661741 | |
| Pubmed | 9.44e-05 | 3 | 196 | 2 | 31323462 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DDX3X GGA3 MAVS SVIL DSC3 EIF4H TMEM51 LARP1 EFHD2 SORBS1 FAM83H SCRIB | 9.60e-05 | 565 | 196 | 12 | 25468996 |
| Pubmed | 9.74e-05 | 399 | 196 | 10 | 35987950 | ||
| Pubmed | CSMD3 GGA3 MAGI2 BOD1L1 SORBS2 EIF4H DLGAP4 SORBS1 IGDCC4 SCRIB | 1.15e-04 | 407 | 196 | 10 | 12693553 | |
| Pubmed | Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling. | 1.21e-04 | 332 | 196 | 9 | 29053956 | |
| Pubmed | SOX9 PDE9A ARMCX4 DDX3X MAGI2 MAP3K11 NR1H2 CNOT2 SORBS2 UBQLN1 SESN3 TRIOBP SORBS1 NFE2L3 HEATR6 MICAL2 CCAR1 SCRIB CABIN1 | 1.31e-04 | 1285 | 196 | 19 | 35914814 | |
| Pubmed | PTPN14 ZFYVE9 DSC2 DSC3 TMEM51 DLGAP4 TRIOBP RAB34 CELSR2 SCRIB | 1.51e-04 | 421 | 196 | 10 | 36976175 | |
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 24726386 | ||
| Pubmed | Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation. | 1.88e-04 | 4 | 196 | 2 | 31923423 | |
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 20127681 | ||
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 16537381 | ||
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 29449313 | ||
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 12356872 | ||
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 26687026 | ||
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 23652796 | ||
| Pubmed | Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation. | 1.88e-04 | 4 | 196 | 2 | 16355270 | |
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 19542565 | ||
| Pubmed | The sorbin homology domain: a motif for the targeting of proteins to lipid rafts. | 1.88e-04 | 4 | 196 | 2 | 11481476 | |
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 23056264 | ||
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 29986868 | ||
| Pubmed | Sorbs1 and -2 Interact with CrkL and Are Required for Acetylcholine Receptor Cluster Formation. | 1.88e-04 | 4 | 196 | 2 | 26527617 | |
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 11335123 | ||
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 28215713 | ||
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 20305638 | ||
| Pubmed | 1.88e-04 | 4 | 196 | 2 | 36763533 | ||
| Pubmed | BCL9 RABL3 STAU1 EFTUD2 MAVS CNOT2 DSC3 EIF4H RBM33 EFHD2 AKT1S1 FAM83H SNW1 RBM6 CCAR1 PALLD | 2.04e-04 | 1007 | 196 | 16 | 34597346 | |
| Pubmed | RRP1B POLR2M AHDC1 DDX3X STAU1 EFTUD2 PTPN14 RECQL5 RECQL4 LARP1 CTDP1 PALLD | 2.10e-04 | 615 | 196 | 12 | 31048545 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RRP1B DDX3X STAU1 EFTUD2 EMG1 PTBP3 EIF4H RBM33 FBRSL1 LARP1 HEATR6 SNW1 RBM6 CCAR1 | 2.12e-04 | 807 | 196 | 14 | 22681889 |
| Pubmed | Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | 2.18e-04 | 21 | 196 | 3 | 22959728 | |
| Interaction | PPP1CC interactions | RRP1B PPP1R12B ZNF318 PRAG1 DDX3X STAU1 EFTUD2 ZFYVE9 SVIL RECQL4 USP36 SORBS2 ZNF629 TRIOBP LARP1 TACC2 SHANK3 PPP1R3D SNW1 P2RY6 SCRIB | 6.84e-06 | 738 | 190 | 21 | int:PPP1CC |
| Interaction | GLDC interactions | RRP1B DDX3X EFTUD2 SVIL RECQL4 EMG1 DSC2 DSC3 ZNF629 LARP1 RBM6 CCAR1 SCRIB | 1.19e-05 | 321 | 190 | 13 | int:GLDC |
| Interaction | YWHAH interactions | PRAG1 DDX3X EFTUD2 PTPN14 GRID2IP BRAF SVIL RECQL4 CC2D2A BOD1L1 WNK2 SORBS2 RPS6KA4 DSC2 ZNF629 LARP1 SORBS1 AKT1S1 FAM83H PPP1R3D RIN1 P2RY6 PRICKLE3 NINL SCRIB PALLD | 1.50e-05 | 1102 | 190 | 26 | int:YWHAH |
| Interaction | TOP3B interactions | PCSK5 CARD10 BCL9 ZNF236 PRAG1 ITGB5 AHDC1 DDX3X GGA3 STAU1 ZGPAT SLC38A10 TNRC18 RECQL5 SVIL MAP3K11 TSR3 PLK3 CNOT2 WNK2 RBM33 FBRSL1 FAM83H HIVEP3 SLC2A4RG CELSR2 KANK3 MDC1 CTDP1 NINL CABIN1 | 1.94e-05 | 1470 | 190 | 31 | int:TOP3B |
| Cytoband | 7p22.1 | 4.98e-05 | 47 | 196 | 4 | 7p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 5.76e-05 | 307 | 196 | 8 | chr17q25 | |
| GeneFamily | Ubiquilin family | 4.90e-04 | 5 | 128 | 2 | 783 | |
| GeneFamily | RecQ like helicases | 4.90e-04 | 5 | 128 | 2 | 1049 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 8.00e-04 | 26 | 128 | 3 | 904 | |
| GeneFamily | Desmosomal cadherins | 1.02e-03 | 7 | 128 | 2 | 1188 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 1.02e-03 | 7 | 128 | 2 | 285 | |
| GeneFamily | Transcription elongation factor A like family | 1.73e-03 | 9 | 128 | 2 | 1216 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_VASCULAR_ENDOTHELIAL_CELLS | 1.14e-06 | 104 | 195 | 8 | M40225 | |
| Coexpression | DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS | CARD10 POLR2M CA8 STAB2 CAVIN3 SHANK3 ARHGEF15 RIN1 KANK3 MMRN2 MADCAM1 | 6.65e-06 | 272 | 195 | 11 | MM3634 |
| Coexpression | GSE3982_BCELL_VS_NKCELL_DN | AVPR1A ITM2A CELSR2 UBQLN3 MMRN2 SCRIB PALLD MADCAM1 SEC14L5 | 1.78e-05 | 197 | 195 | 9 | M5548 |
| Coexpression | GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP | 1.86e-05 | 198 | 195 | 9 | M4309 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP | 2.01e-05 | 200 | 195 | 9 | M7501 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP | 2.01e-05 | 200 | 195 | 9 | M7411 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-07 | 185 | 196 | 9 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.67e-07 | 189 | 196 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PPP1R12B TMEM132B MAGI2 COL6A3 NTRK3 CAVIN3 ARMC9 SMTN PALLD | 1.83e-07 | 191 | 196 | 9 | 08042952431ca1a6fd7dfc13f36eb28643979598 |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CARD10 MAP3K11 ITM2A CA8 SHANK3 ARHGEF15 KANK3 MMRN2 MADCAM1 | 2.09e-07 | 194 | 196 | 9 | 32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CARD10 MAP3K11 ITM2A CA8 SHANK3 ARHGEF15 KANK3 MMRN2 MADCAM1 | 2.18e-07 | 195 | 196 | 9 | 3826bfafe85f8aa9a508202ceb2b02e81b090498 |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.18e-07 | 195 | 196 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.18e-07 | 195 | 196 | 9 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | wk_08-11-Endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | CARD10 ITM2A STAB2 SHANK3 ARHGEF15 KANK3 ANGPTL4 MMRN2 MADCAM1 | 2.28e-07 | 196 | 196 | 9 | 0e545874083fd8e954a49fc397d57a86b081008b |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-06 | 176 | 196 | 8 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-06 | 176 | 196 | 8 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.17e-06 | 122 | 196 | 7 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-06 | 180 | 196 | 8 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-06 | 183 | 196 | 8 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.63e-06 | 184 | 196 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.77e-06 | 186 | 196 | 8 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 187 | 196 | 8 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.84e-06 | 187 | 196 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 187 | 196 | 8 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 187 | 196 | 8 | 81754e965848b718be20ee97ce072ce426938a69 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.92e-06 | 188 | 196 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 189 | 196 | 8 | e002dbb2138a6264be23f3b8148275a0cef351ef | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-06 | 190 | 196 | 8 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-06 | 190 | 196 | 8 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.07e-06 | 190 | 196 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.16e-06 | 191 | 196 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.16e-06 | 191 | 196 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 191 | 196 | 8 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 191 | 196 | 8 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 193 | 196 | 8 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.33e-06 | 193 | 196 | 8 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.42e-06 | 194 | 196 | 8 | 4199900d16623eca02d674d5ada7f0989e47955e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.42e-06 | 194 | 196 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.52e-06 | 195 | 196 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.55e-06 | 137 | 196 | 7 | 9bfdbc102cdd861996b3c4eac35b606be8af97eb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 196 | 196 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 196 | 196 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Early_cap|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.61e-06 | 196 | 196 | 8 | 0f00aac6dac699507ce336020b2e96fd192de0be | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-06 | 196 | 196 | 8 | 20dc9b25ecc23b6e6e52bbab8b5a404f3245ca37 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-06 | 197 | 196 | 8 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.71e-06 | 197 | 196 | 8 | 88859b7b24b36afab4a684fd7abf0e0f8e5b525c | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-06 | 197 | 196 | 8 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.71e-06 | 197 | 196 | 8 | a07ab2564ca7d577fd47f444dd7b0c25556e9fc4 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-06 | 197 | 196 | 8 | f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.71e-06 | 197 | 196 | 8 | 2ed92f942475db6836e48da3c6b8235eb8691c38 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-06 | 197 | 196 | 8 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-06 | 197 | 196 | 8 | 131bc6ef55f467cc802db68daf7e7d757ea64fc6 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.71e-06 | 197 | 196 | 8 | 9b3d6fe76dd7d61a286a28d9466b5f2fece048e1 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.82e-06 | 198 | 196 | 8 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | wk_15-18-Endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.82e-06 | 198 | 196 | 8 | dcf453e22dba90c0ae349fa6c3d4c20758bb95af | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.82e-06 | 198 | 196 | 8 | 75270600b5b29187dfa86f01f8f927ae0621cda4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.82e-06 | 198 | 196 | 8 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | wk_20-22-Endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.92e-06 | 199 | 196 | 8 | 07be9509a8ec9c9a7d721912d77c20e841f49808 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.92e-06 | 199 | 196 | 8 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.92e-06 | 199 | 196 | 8 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-06 | 199 | 196 | 8 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-06 | 199 | 196 | 8 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-06 | 200 | 196 | 8 | 4fb6fd703aca9a992924245105ad99163146a415 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-06 | 200 | 196 | 8 | ae429f2de652cc1976e63644781197e9ce0e70c8 | |
| ToppCell | proximal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.03e-06 | 200 | 196 | 8 | 0ff4185021ec84b57be13b28495e2f8a4d195eb6 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.03e-06 | 200 | 196 | 8 | e4f6e0b9502eb531f28d605f9dbda6a72a9ed320 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.03e-06 | 200 | 196 | 8 | d034bd210c87b704acf45f50d888497c8737011b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.03e-06 | 200 | 196 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.03e-06 | 200 | 196 | 8 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-06 | 200 | 196 | 8 | b50de1f8c8f598e281951e4587f2d96c11aac836 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-06 | 156 | 196 | 7 | 1928c86deb3bcd01db4ae76919a351066aadb39a | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.71e-06 | 162 | 196 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-7|TCGA-Kidney / Sample_Type by Project: Shred V9 | 9.04e-06 | 166 | 196 | 7 | b545de32578047c9ca422354b8992f2d9c9e1cc7 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-06 | 168 | 196 | 7 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 171 | 196 | 7 | 0de81d12a8000f2c59cdb214e67dc526d18098fe | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 171 | 196 | 7 | 0597339618fb4d416d55c538eceb353218a55002 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 171 | 196 | 7 | 35acc5c3e36bc605603c0d45375f2cf3c3e9d4cd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-05 | 173 | 196 | 7 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-05 | 173 | 196 | 7 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | Severe-B_naive-13|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.26e-05 | 116 | 196 | 6 | f81a7c3e9cbf39124232d98e2a3a3e308137f391 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(Ndrg2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.34e-05 | 69 | 196 | 5 | 3f6902cb62d6130b3d3a1cf122dbc695f7349ffe | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(Ndrg2)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.34e-05 | 69 | 196 | 5 | 832ed163f553481b49bbf8a1eb10cbd8afab4e34 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-05 | 178 | 196 | 7 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-05 | 178 | 196 | 7 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.42e-05 | 178 | 196 | 7 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.42e-05 | 178 | 196 | 7 | 9e426ce23a4a33b91d139ad85685cf8483bcd01a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.42e-05 | 178 | 196 | 7 | c90e9048fc786ba8559972ae25c25ecab4bc1b7c | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.48e-05 | 179 | 196 | 7 | 56fe381ffbaba3a4f2f587a3e367b0d11fbd4a2a | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-05 | 179 | 196 | 7 | 7aa4137f672dadb3be92009cde6e0ea60a15372d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 180 | 196 | 7 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 180 | 196 | 7 | 0677bf4a5177d9cbc6716195bd966eeae8de2f31 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-05 | 181 | 196 | 7 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-05 | 182 | 196 | 7 | 63b41b538b26bc899558807fd035e543611f8c52 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 182 | 196 | 7 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 182 | 196 | 7 | 1c1a687f728341c209b048b6715bcddd0ac20069 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 182 | 196 | 7 | 97bb07478f56a937b490fba121ee603db64134a1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 182 | 196 | 7 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-05 | 184 | 196 | 7 | fa38d6a8709f520a027ad7e3ff783c84187ec467 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 184 | 196 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 185 | 196 | 7 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 185 | 196 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.83e-05 | 185 | 196 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 185 | 196 | 7 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-05 | 186 | 196 | 7 | 055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.89e-05 | 186 | 196 | 7 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 186 | 196 | 7 | 0de87109da9324c597fadf2eb782f0f158afe832 | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A | MAN2C1 ZBTB17 RRP1B ITGB5 DDX3X RECQL5 SVIL PTBP3 DSC2 CTDP1 | 6.78e-06 | 194 | 194 | 10 | 4648_DN |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A | RRP1B PPP1R12B ZNF318 BCL9 BRAF PTBP3 DSC2 RIN1 HEATR6 MICAL2 | 7.09e-06 | 195 | 194 | 10 | 7400_DN |
| Drug | Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | BCORL1 GGA3 TYRP1 TAX1BP1 RECQL5 CCDC40 DSC3 HIVEP3 RIN1 SPIDR | 8.86e-06 | 200 | 194 | 10 | 6787_UP |
| Disease | bronchopulmonary dysplasia | 8.91e-06 | 45 | 184 | 5 | MONDO_0019091 | |
| Disease | Malignant neoplasm of breast | TRIML1 MAN2C1 PPP1R12B PXDC1 BCORL1 ZNF318 DDX3X GGA3 PTPN14 BRAF TAX1BP1 GOLIM4 DIO3 BOD1L1 DSC3 TACC2 SORBS1 PRICKLE3 ANGPTL4 PCDH8 | 1.37e-05 | 1074 | 184 | 20 | C0006142 |
| Disease | triglycerides in small LDL measurement | 5.45e-05 | 65 | 184 | 5 | EFO_0022323 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.02e-04 | 74 | 184 | 5 | EFO_0022280 | |
| Disease | Hypertriglyceridemia | 1.03e-04 | 15 | 184 | 3 | C0020557 | |
| Disease | coronary artery disease | HGFAC RRP1B PPP1R12B TRIM65 ITGB5 AHDC1 FAP PKHD1 WNK2 COL6A3 SORBS2 DOCK8 DUOX2 CELSR2 LPL ANGPTL4 CABIN1 PALLD UNC13A | 1.81e-04 | 1194 | 184 | 19 | EFO_0001645 |
| Disease | cholesterol to total lipids in small HDL percentage | 2.91e-04 | 51 | 184 | 4 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 2.91e-04 | 51 | 184 | 4 | EFO_0022242 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 3.38e-04 | 53 | 184 | 4 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 3.63e-04 | 54 | 184 | 4 | EFO_0022244 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology) | 3.82e-04 | 5 | 184 | 2 | DOID:0050431 (implicated_via_orthology) | |
| Disease | desmocollin-2 measurement | 3.82e-04 | 5 | 184 | 2 | EFO_0021936 | |
| Disease | triglycerides in medium VLDL measurement | 3.89e-04 | 55 | 184 | 4 | EFO_0022155 | |
| Disease | cholesterol to total lipids in large HDL percentage | 3.89e-04 | 55 | 184 | 4 | EFO_0022234 | |
| Disease | triglycerides in LDL measurement | 4.17e-04 | 56 | 184 | 4 | EFO_0022320 | |
| Disease | Colorectal Carcinoma | ELOA2 CSMD3 DEFA4 BRAF PKHD1 MMP11 AMPD1 RELCH FRMPD2 SMTN HIVEP3 MMRN2 CCAR1 | 4.92e-04 | 702 | 184 | 13 | C0009402 |
| Disease | total lipids in VLDL measurement | 5.43e-04 | 60 | 184 | 4 | EFO_0022314 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 5.71e-04 | 6 | 184 | 2 | EFO_0800611 | |
| Disease | triglycerides in small VLDL measurement | 5.79e-04 | 61 | 184 | 4 | EFO_0022145 | |
| Disease | triglycerides in medium LDL measurement | 6.16e-04 | 62 | 184 | 4 | EFO_0022322 | |
| Disease | white matter hyperintensity measurement | 6.48e-04 | 302 | 184 | 8 | EFO_0005665 | |
| Disease | cholesterol in large VLDL measurement | 7.36e-04 | 65 | 184 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 7.36e-04 | 65 | 184 | 4 | EFO_0022230 | |
| Disease | total lipids in very large HDL measurement | 7.80e-04 | 66 | 184 | 4 | EFO_0022312 | |
| Disease | Sacral agenesis | 7.96e-04 | 7 | 184 | 2 | C0344490 | |
| Disease | total lipids in large VLDL | 8.26e-04 | 67 | 184 | 4 | EFO_0022175 | |
| Disease | triglycerides in very small VLDL measurement | 8.73e-04 | 68 | 184 | 4 | EFO_0022144 | |
| Disease | triglycerides to phosphoglycerides ratio | 8.73e-04 | 68 | 184 | 4 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 8.73e-04 | 68 | 184 | 4 | EFO_0022265 | |
| Disease | glycoprotein measurement | 9.19e-04 | 119 | 184 | 5 | EFO_0004555 | |
| Disease | cholesterol in very large HDL measurement | 9.22e-04 | 69 | 184 | 4 | EFO_0022229 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 9.43e-04 | 31 | 184 | 3 | EFO_0022249 | |
| Disease | Ventricular Septal Defects | 1.06e-03 | 8 | 184 | 2 | C0018818 | |
| Disease | advanced glycation end-product measurement, type 2 diabetes mellitus | 1.06e-03 | 8 | 184 | 2 | EFO_0007819, MONDO_0005148 | |
| Disease | triglyceride measurement, physical activity | 1.24e-03 | 34 | 184 | 3 | EFO_0003940, EFO_0004530 | |
| Disease | Pancreatic carcinoma, familial | 1.35e-03 | 9 | 184 | 2 | C2931038 | |
| Disease | vein graft stenosis | 1.35e-03 | 9 | 184 | 2 | EFO_0007051 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 1.46e-03 | 36 | 184 | 3 | EFO_0022257 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.59e-03 | 37 | 184 | 3 | EFO_0022252 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 1.68e-03 | 10 | 184 | 2 | EFO_0800333 | |
| Disease | psoriasis | 1.69e-03 | 273 | 184 | 7 | EFO_0000676 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.72e-03 | 137 | 184 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | Autism Spectrum Disorders | 2.00e-03 | 85 | 184 | 4 | C1510586 | |
| Disease | Intellectual Disability | 2.06e-03 | 447 | 184 | 9 | C3714756 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.14e-03 | 144 | 184 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Combined immunodeficiency | 2.14e-03 | 41 | 184 | 3 | C0494261 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 2.29e-03 | 42 | 184 | 3 | EFO_0022255 | |
| Disease | metabolite measurement, body weight gain | 2.45e-03 | 12 | 184 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | free cholesterol to total lipids in IDL percentage | 2.45e-03 | 43 | 184 | 3 | EFO_0022278 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 2.45e-03 | 43 | 184 | 3 | EFO_0022254 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.78e-03 | 153 | 184 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.78e-03 | 153 | 184 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | pulse pressure measurement | HGFAC TRIM65 ZNF318 ITGB5 AHDC1 PRPF40B FGR USP36 COL6A3 RILPL2 RBM33 DLGAP4 FBRSL1 TRIOBP HIVEP3 LPL PALLD HYDIN | 2.82e-03 | 1392 | 184 | 18 | EFO_0005763 |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 2.88e-03 | 94 | 184 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.96e-03 | 225 | 184 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | age at menopause | 2.97e-03 | 302 | 184 | 7 | EFO_0004704 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.03e-03 | 303 | 184 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | phospholipids:total lipids ratio | 3.10e-03 | 227 | 184 | 6 | EFO_0020946 | |
| Disease | serum alanine aminotransferase measurement | HGFAC BCORL1 PRAG1 GINS1 ZGPAT STRADA RECQL4 WNK2 PNP RILPL2 GPT CELSR2 RBM6 | 3.28e-03 | 869 | 184 | 13 | EFO_0004735 |
| Disease | respiratory quotient | 3.35e-03 | 14 | 184 | 2 | EFO_0005189 | |
| Disease | CD209 antigen measurement | 3.35e-03 | 14 | 184 | 2 | EFO_0008077 | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 3.35e-03 | 14 | 184 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 3.48e-03 | 99 | 184 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | triglyceride measurement, alcohol drinking | 3.48e-03 | 99 | 184 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 3.48e-03 | 99 | 184 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.56e-03 | 49 | 184 | 3 | EFO_0022256 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 3.73e-03 | 101 | 184 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 3.85e-03 | 15 | 184 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 3.87e-03 | 102 | 184 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.93e-03 | 166 | 184 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | creatinine measurement | HGFAC ZBTB17 CARD10 FAP PTPN14 SVIL PKHD1 MAP3K11 MMP11 AMPD1 ARMC9 CELSR2 AP5B1 LPL | 3.98e-03 | 995 | 184 | 14 | EFO_0004518 |
| Disease | mean corpuscular hemoglobin concentration | ZNF318 ITGB5 STT3A ZGPAT EMG1 CC2D2A CCDC40 DLGAP4 FBRSL1 LARP1 ARHGEF15 IGDCC4 TRIM10 SLC2A4RG LPL | 4.05e-03 | 1105 | 184 | 15 | EFO_0004528 |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 4.14e-03 | 104 | 184 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | phospholipids in medium VLDL measurement | 4.21e-03 | 52 | 184 | 3 | EFO_0022154 | |
| Disease | familial hyperlipidemia | 4.43e-03 | 106 | 184 | 4 | MONDO_0001336 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 4.44e-03 | 53 | 184 | 3 | EFO_0022340 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 4.44e-03 | 53 | 184 | 3 | EFO_0022286 | |
| Disease | total lipids in medium VLDL | 4.69e-03 | 54 | 184 | 3 | EFO_0022153 | |
| Disease | peripheral arterial disease | 4.69e-03 | 54 | 184 | 3 | EFO_0004265 | |
| Disease | triglycerides in medium HDL measurement | 4.69e-03 | 54 | 184 | 3 | EFO_0022321 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 5.06e-03 | 110 | 184 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | triglycerides in large VLDL measurement | 5.19e-03 | 56 | 184 | 3 | EFO_0022178 | |
| Disease | von Willebrand factor measurement | 5.19e-03 | 56 | 184 | 3 | EFO_0004629 | |
| Disease | triglycerides in very large VLDL measurement | 5.19e-03 | 56 | 184 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 5.19e-03 | 56 | 184 | 3 | EFO_0022333 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 5.19e-03 | 56 | 184 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 5.19e-03 | 56 | 184 | 3 | EFO_0022250 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 5.22e-03 | 111 | 184 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | lipoprotein A measurement | 5.39e-03 | 112 | 184 | 4 | EFO_0006925 | |
| Disease | pancreatic cancer (is_implicated_in) | 5.39e-03 | 112 | 184 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 5.45e-03 | 57 | 184 | 3 | EFO_0022284 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 5.54e-03 | 18 | 184 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | triglycerides in IDL measurement | 5.72e-03 | 58 | 184 | 3 | EFO_0022149 | |
| Disease | low density lipoprotein particle size measurement | 5.72e-03 | 58 | 184 | 3 | EFO_0008593 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 5.72e-03 | 58 | 184 | 3 | EFO_0022338 | |
| Disease | antihyperlipidemic drug use measurement | 5.91e-03 | 115 | 184 | 4 | EFO_0803367 | |
| Disease | triglycerides in VLDL measurement | 6.00e-03 | 59 | 184 | 3 | EFO_0022326 | |
| Disease | triglycerides to total lipids in small LDL percentage | 6.00e-03 | 59 | 184 | 3 | EFO_0022337 | |
| Disease | cholesterol in medium HDL measurement | 6.00e-03 | 59 | 184 | 3 | EFO_0021903 | |
| Disease | adverse effect, response to xenobiotic stimulus | 6.00e-03 | 59 | 184 | 3 | EFO_0009658, GO_0009410 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLRTIRQSNEEGPGE | 81 | Q9UPW8 | |
| ERRDGGIPADPNNVF | 141 | P24298 | |
| QRENSPAAFPDREGV | 736 | Q9Y5B0 | |
| SENRRPLEAGSPGQD | 131 | Q9HCM7 | |
| PVNIDDLIRDQGFRG | 376 | P15056 | |
| EDTQVFGDLPRPRLN | 231 | Q96B36 | |
| LQQEASRPGAPGSER | 301 | Q9BWT7 | |
| LFPVLPGNGRVTQED | 411 | Q4G0S4 | |
| ERQSGLFEIQPQGSP | 196 | Q9BY76 | |
| RLGPGRSAEAQPEAQ | 211 | Q969G5 | |
| DPGIPINARRFGDNF | 836 | Q7Z407 | |
| VPEPRFGRRIGNEFA | 1881 | Q7Z407 | |
| EGGDIAFIPSPQRLE | 111 | P54284 | |
| DPPSRFSGRNDRGDQ | 296 | Q8IX12 | |
| FRADGLPVAPQRGQA | 1066 | Q5H9F3 | |
| PEPGLQARADVNGER | 171 | O94989 | |
| GEDPFRTDNLPENLG | 191 | P23109 | |
| AQAPGLRAGERSPEE | 151 | Q9HCU4 | |
| LPSQSRAFGVGERDP | 1326 | Q5TGY3 | |
| AREARFPGQNTLPGD | 41 | Q9Y2H0 | |
| YSIRGPGVDQEPRNL | 171 | Q02487 | |
| EARPGATVDARGNPN | 251 | Q5H9R4 | |
| FDLELPDGNRQVRGV | 181 | Q76LX8 | |
| RTEVGPGPFSRLQDV | 926 | Q8TDY8 | |
| QDRDPFFLGVSGEPR | 456 | Q96EV2 | |
| RPNLLEEGGNDIPAA | 261 | Q8NHB8 | |
| QPGVDQRGLAQPRAD | 566 | Q9H0J4 | |
| REGNQIPGFPDRKRF | 211 | Q5HYI8 | |
| PQNGEVRLRGPLDFE | 296 | Q9Y5F3 | |
| GRVGPNAEPRFRDEF | 1071 | Q9P260 | |
| GRAPNQPRVDFSGIA | 86 | Q8WTU0 | |
| PPSERLEQELFSGGN | 141 | O00571 | |
| GPQDPEESASRQRFG | 86 | Q8IYF1 | |
| EGTGQQERESPRPLQ | 66 | Q6PKG0 | |
| ANPNSAIFGGARPRE | 226 | Q15056 | |
| LVQQLFPGPGVRDAD | 111 | Q9NPI8 | |
| RRPEISQAGPTQGEV | 291 | Q13477 | |
| PQREGAQVPTGRERE | 661 | Q14676 | |
| GGPRPQADRKFQERE | 491 | Q7Z434 | |
| QRAARPRLEEAPGGQ | 1321 | Q86UL8 | |
| PGNPQGAFLIRESET | 161 | P09769 | |
| TEINCRRPDDGNLFP | 41 | Q16288 | |
| EGAPESRALRQDPGD | 1271 | Q6PRD1 | |
| RRGQPEPEVELNSEG | 76 | P55073 | |
| GARPEPDSLQARLGQ | 361 | Q9H8L6 | |
| REAPQDPGNGVTTRE | 741 | Q7Z3E5 | |
| SPGIPFQTEEGRRDD | 3706 | Q2LD37 | |
| DPDQRGDVVLPFQRS | 141 | Q9NRD8 | |
| TRDPQDPSGRQGELS | 21 | Q96J88 | |
| VDGPAPLTRQAFENG | 281 | Q92824 | |
| VNRITGLDPAGPNFE | 176 | P06858 | |
| RVGDENDNAPLFTRP | 486 | O95206 | |
| PQPFEEGLRRLQEGD | 336 | P50542 | |
| QPRREGAFESGQVEP | 116 | O76083 | |
| ELRSNGEEPRFQELP | 441 | Q6P3R8 | |
| FSRLRDDQGRPVNPN | 646 | Q9Y4A8 | |
| DSQGNPGEDPRFEIV | 216 | Q9ULS6 | |
| REAPREAIPERGNGF | 16 | Q6AI08 | |
| QREQSDLDFFSPRPG | 421 | Q9NZ52 | |
| APFRPQIRSELDVGN | 316 | O75676 | |
| SDLGRGFVPASEQRP | 131 | Q2VPB7 | |
| AFRLERAQDPDGGLN | 151 | Q9UN67 | |
| PGFAGRLCNIEPDER | 271 | Q04756 | |
| VINPDDRVFEQGGAR | 91 | Q86U28 | |
| RNRDAPEGGFDAVLQ | 241 | P18084 | |
| GNRHEPREQGPREAD | 521 | O00461 | |
| SGDENEPIQERFFRP | 1121 | Q8WX93 | |
| QPNLRPDDSAFGRQS | 456 | O43900 | |
| RGLEEQVPPGFSEAQ | 126 | Q86VR8 | |
| PGARTRGQQRVEEAP | 3031 | Q8NFC6 | |
| AQRSEEPPSERGGIF | 396 | Q96EW2 | |
| RGQGLEPRLEFSPSV | 1816 | Q4G0P3 | |
| QAFREAPGRLSEPDQ | 951 | A4D2P6 | |
| RSGDPPGNFQLDIDI | 396 | Q9P2K1 | |
| VAFPQGLPAGAEEQR | 1491 | Q9Y6J0 | |
| RRAPGNDRFPGLNEN | 1381 | Q8NF50 | |
| GVNNEAPFARDIPRV | 436 | Q14574 | |
| PGADPQDQQAGRRLS | 266 | Q68DX3 | |
| QAPFLPQARGPDQRD | 216 | O43559 | |
| PQARGPDQRDPQVFL | 221 | O43559 | |
| GRGERFPNPQGLSEE | 616 | O00512 | |
| GDNFRPTQPLSDRVI | 271 | P35219 | |
| FQQEATGPPESRERR | 141 | Q4G0X9 | |
| NPRFGPREGQEENKI | 31 | P86791 | |
| FVPEAGSRLDQRVPQ | 1731 | P12111 | |
| DQREVNTSGFAPARP | 311 | P01880 | |
| NPRFGPREGQEENKI | 31 | P86790 | |
| NPFRSLEPEGDARSG | 371 | Q7Z7H3 | |
| LPNDFVERGVQDLPG | 481 | O75342 | |
| LRGGEPNFLPVTEEA | 101 | O43736 | |
| QRDFRPAQVGDSFGP | 61 | Q9NTJ4 | |
| QSLLPERGGSDPQRQ | 511 | Q8NFN8 | |
| AGRAQPEPDGEAETR | 226 | Q6NY19 | |
| EGNPRGTDLENPREA | 1376 | Q76NI1 | |
| RRADLNQGIGEPQSP | 61 | Q96C19 | |
| SRINIPERASGPEGN | 51 | Q5XKR9 | |
| QENGQPESPRRLSLG | 991 | Q6ZRV2 | |
| RGFEPQAPEDLAQRS | 6 | P0CAP2 | |
| RRISAHQPGPEGQEE | 286 | Q96G97 | |
| QVRAGPLQARGDEAP | 16 | P12838 | |
| PLQARGDEAPGQEQR | 21 | P12838 | |
| VREEDARNQAGPRDP | 186 | O43304 | |
| VGPAPFNLQRQGSRE | 736 | Q9UJQ4 | |
| PRGGEDAAVQEPRQR | 1001 | Q9HBR0 | |
| FSGQNPLRGPNDERF | 141 | P00491 | |
| ECRGLEPVDFQPQAG | 101 | Q9NWV4 | |
| DRRRNVFEVGPGDSP | 511 | Q16584 | |
| EGLRRQSPPASGEVN | 101 | Q969X0 | |
| RAAGEPLPTQRGAQE | 1496 | O94851 | |
| RQDGPAEPVAQERRG | 221 | Q15077 | |
| FPAAELAQAGPERQR | 81 | C0HLS1 | |
| PERQRDPAVASRGGQ | 91 | C0HLS1 | |
| PNRPGITFEIGARLE | 6 | A8MW92 | |
| GVPDPSDGLSARNRQ | 81 | P24347 | |
| RDSDAGREGQEPQPR | 56 | Q6KF10 | |
| DAGEAEARARGPQQP | 241 | Q6KF10 | |
| RPRVLLQSSEPGDQG | 926 | Q5ST30 | |
| NPDRPAAGQTDRERE | 301 | Q8NEY4 | |
| RPANRTGPFRGSQEE | 6 | P78332 | |
| RDEGSRPDRQPEFTQ | 266 | Q6PI48 | |
| DLELFGEQPPGDTRR | 26 | Q7RTN6 | |
| RAGPEPQELQGIRQA | 391 | Q13671 | |
| SQPARNFSRPDGLED | 676 | Q86VP1 | |
| FPEDRSELAQGPLRQ | 71 | Q5TGL8 | |
| PSLEQNRGREPEASG | 421 | Q14684 | |
| GDGLVRSPEDPSRNE | 461 | O95425 | |
| LESPQQAFPARERIG | 246 | Q14DG7 | |
| QRGRRPSQDDVEAAP | 21 | O94761 | |
| NIFSADRPNVQEPGR | 376 | P55055 | |
| ARRNTLREQGPPEEG | 666 | Q15678 | |
| RPPGFDRVRNAEIGN | 656 | P46977 | |
| QSFVEPFQCPRRGEG | 16 | A6NKW6 | |
| FLDEQNRRVESLGPP | 3766 | P08F94 | |
| EGGRQPPIDFRDVDI | 261 | P48436 | |
| QGPLPRGSQRSEQLE | 766 | Q9Y2I6 | |
| PGGENRDVEAQRLVP | 756 | E7EW31 | |
| ANGQRALPRDGPLDE | 146 | O75783 | |
| EEENQSGPPARGRRG | 556 | O94875 | |
| ELRTQRPLESGQAGP | 1406 | Q9H2D6 | |
| PRRGLGAPLTEDQQN | 2006 | Q9H2D6 | |
| QPSGNPRVDSGFVDR | 221 | E9PGG2 | |
| FPLDNTPVRNRGDGD | 216 | Q9NPC3 | |
| PALADRNRREGSGNP | 231 | Q9NZN8 | |
| DVNNPGLRVRAQPGD | 556 | Q96SZ6 | |
| TRIREQAPQPERGGE | 676 | O94762 | |
| SNGEFVRGNELPRPI | 136 | Q12884 | |
| FDERPGPIQIASQAR | 381 | O15417 | |
| PRNIRVGDGDAAAPE | 646 | Q32MQ0 | |
| VGDFGLAARLEPPEQ | 201 | Q9H4B4 | |
| AGDLQVRPRGDTPQA | 106 | Q2TAL6 | |
| TEDGPIRRNPAGNVA | 306 | P17643 | |
| PEGPQRIVLQGDNRS | 521 | A0A0J9YY54 | |
| PLEENVGNAARPRFE | 6 | P23510 | |
| DDPTQNRNRIASFPG | 136 | Q96BF3 | |
| RNLPVNFEVARESGP | 196 | O95793 | |
| AGLEFARPQESEPRA | 51 | Q9NR83 | |
| ADRPGPLFVDVQARD | 1136 | Q9BYB0 | |
| GNGRLEQRPEDRGAF | 801 | Q14159 | |
| GINPERDPEISNGFR | 211 | P58005 | |
| GEGSQPSRTENRDPL | 306 | Q9UMX0 | |
| LVNTDRGQEGTARPP | 166 | Q9BX66 | |
| QRDVQDPFAPRGQRG | 166 | Q6IPX3 | |
| RRGEPEEDAPASQRG | 1711 | Q5T1R4 | |
| RADVEASPGNPPDRQ | 176 | Q9NW97 | |
| FPEEPERNGVAPGAQ | 276 | P29144 | |
| RFFTPAIRQGPEGLE | 46 | Q8TDP1 | |
| LPRQDDNGVRPTIGQ | 316 | Q9Y6L7 | |
| PPVEAADFGERLQRQ | 161 | O95685 | |
| ETSAPGEQPQFLGVR | 911 | Q9BY07 | |
| QDPLQPTETRFVDGR | 2411 | Q8WWQ8 | |
| VFPEQPGQEGRLDLD | 606 | Q9BRR9 | |
| RELQQAELPNRSPGF | 821 | Q6NWY9 | |
| SDRERGQGEAPPQYL | 286 | O95359 | |
| RGREGPVQFEEDPFG | 486 | Q13573 | |
| GPTVAAPQERSGREQ | 856 | Q9P2J2 | |
| GPRRELVQQPGTSEE | 1331 | Q86YV5 | |
| RDFTRLDLPTGDGQP | 271 | O95758 | |
| QRDVQDPFAPRGQRG | 166 | Q969E4 | |
| GEGNGPPRDVRNEEL | 36 | P37288 | |
| NGRDPGEARPDITHQ | 76 | Q92979 | |
| GGSRQQLPDNPERFD | 311 | Q8N9V2 | |
| FRPRDGAEGQPALAE | 776 | Q13105 | |
| AVSPELGQRIRDFPQ | 271 | Q9UDY6 | |
| PEGRRLPQSLSQEGD | 121 | P17020 | |
| FAQQRVPEGGPLLDT | 186 | Q16587 | |
| SPFLPGSIREENGVR | 466 | Q9UL36 | |
| RVFPALAGQAPEEQG | 6 | Q6R2W3 | |
| GDRDFTLEPLRGDQP | 1616 | Q9Y3S1 | |
| TEPRGNEEAQIFRPL | 566 | Q15029 | |
| NEPSLRELVQGRPAG | 131 | Q9UEG4 | |
| APEGQLPAFNEDGLR | 16 | Q14691 | |
| REPFPDGAELRRNVA | 51 | Q6PJ69 | |
| LNPCRGTERVDPGFE | 131 | P0C6A0 | |
| RLGDRIPFEGANEPD | 36 | P01282 | |
| LDFETEGERNSPNPR | 2081 | Q5VUA4 | |
| DGDQDAPDIRNRFPN | 321 | Q9H347 | |
| LENRAGGPVARSEEP | 426 | P53814 | |
| GGRPAPRNVFDFLNE | 406 | Q8N5A5 | |
| PDSPDNDLRAGQFGI | 666 | O95405 | |
| FVGEPQRLGSETRLP | 816 | Q9P275 | |
| GVVQEPPGRASRFLQ | 231 | Q9H808 | |
| PFDVDSGREFGNPNR | 236 | Q9UJK0 | |
| LRFPRAIPAEEEGQG | 2506 | Q9Y493 | |
| VPEEGGRFARAQRLP | 166 | P0DI83 | |
| TEQEPAERRGAGRQP | 31 | O60237 |